Achari AE,Jain SK .2017 .Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int. J. Mol. Sci, 18(1321) : 1-17.
Bastard JP,Maachi M,Lagathu C,Kim MJ,Caron M,Vidal H,Capeau J,Feve B .2006 .Recent Advances in the Relationship between Obesity, Inflammation, and Insulin Resistance. Eur. Cytokine Netw, 17 : 4-12.
Berger S,Ceccarini G,Scabia G,Barone I,Pelosini C,Ferrari F,Magno S,Dattilo A,Chiovato L,Vitti P,Santini F,Maffei M .2017 .Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype. Int. J. Obes, 41 : 1676-1684.
de Souza CG,Sattler JA,de Assis AM,Rech A,Perry ML,Souza DO .2012 .Metabolic effects of sulforaphane oral treatment in streptozotocindiabetic rats. J. Med, 15(9) : 795-801.
Faggioni R,Moser A,Feingold KR,Grunfeld C .2000 .Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am. J. Pathol, 156 : 1781-1787.
Feng H,Zheng L,Feng Z,Zhao Y,Zhang N .2013 .The role of leptin in obesity and the potential for leptin replacement therapy. Endocrine, 44 : 33-39.
Folbergrová J,Ješina P,Otáhal J .2023 .Protective Effect of Sulforaphane on Oxidative Stress and Mitochondrial Dysfunction Associated with Status Epilepticus in Immature Rats. Mol. Neurobiol, 60 : 2024-2035.
Guan Z,Zhou L,Zhang Y,Chen H,Shao F .2021 .Sulforaphane ameliorates the liver injury of traumatic hemorrhagic shock rats. J. Surg. Res, 267 : 293-301.
Guilherme A,Henriques F,Bedard AH,Czech MP .2019 .Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus. Nat. Rev. Endocrinol, 15 : 207-225.
Hamann A,Matthaei S .1996 .Regulation of energy balance by leptin. Exp. Clin. Endocrinol Diabetes, 104(4) : 293-300.
Haslam DW,James WP .2005 .. , 366(9492) : 1197-209.
Hua D,Luo A.,Huang WZ,Li C,Xu SX,Liu C .2022 .Sulforaphane improves cognitive dysfunction after surgery and anesthesia in mice: the role of Keap1-Nrf2 signaling. Brain Research Bulletin, 181(1) : 1-11.
Ioannides-Demos LL,Proietto J,McNeil JJ .2005 .Pharmacotherapy for obesity. Drugs, 65(10) : 1391-1418.
Inui A,Asakawa A,Bowers CY,Mantovani G,Laviano A,Meguid MM,Fujimiya M .2004 .gastric motility: The emerging role of the stomach as an endocrine organ. FASEB J, 18 : 439-456.
Kaynar H,Meral M,Turhan H,Keles M,Celik G,Akcay F .2005 .Glutathione peroxidase, glutathione s-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett, 227 : 133-139.
Liu YL,Fu XZ,Chen ZY,Luo TT,Zhu CX,Ji YT,Bian Z .2021 .The Protective Effects of Sulforaphane on High-Fat Diet-Induced Obesity in Mice Through Browning of White Fat. Front. Pharmacol, 12 : 665894.
Luo J,Alkhalidy H,Jia Z,Liu D .2024 .Sulforaphane Ameliorates High-Fat-DietInduced Metabolic Abnormalities in Young and Middle-. Aged Obese Male Mice Foods, 13(1055) : 1-14.
Mirmiran P,Sherafat-Kazemzadeh R,Jalali-Farahani S and Azizi F .2010 .Childhood obesity in the Middle East: a review. East Mediterr. Health J, 16(9) : 1009-1017.
Mitrou P,Lambadiari V,Maratou E,Boutati E,Komesidou V,Papakonstantinou A,Raptis SA,Dimitriadis G .2011 .Skeletal muscle insulin resistance in morbid obesity: The role of inter- leukin-6 and leptin. Exp. Clin. Endocrinol Diabetes, 119 : 484-489.
Morgen CS,Sorensen TI .2014 .Global trends in the prevalence of overweight and obesity. Nat. Rev. Endocrinol, 10(9) : 513-514.
Munzberg H,Myers MG H .2005 .Molecular and anatomical deter minants of central leptin resistance. Nat. Neurosci., 8 : 566-570.
Nigro E,Scudiero O,Monaco ML,Palmieri A,Mazzarella G,Costagliola C,Bianco A,Daniele A .2014 .New insight into adipo nectin role in obesity and obesity-related diseases. Biomed. Res. Int., 658913, : .
Noble RMN,Jahandideh F,Armstrong EA,Bourque SL,Yager JY .2022 .Broccoli Sprouts Promote Sex-Dependent Cardiometabolic Health and Longevity in Long-Evans Rats. Int. J. Environ. Res. Public Health, 19 : 13468.
Ntzouvani A,Fragopoulou E,Panagiotakos D,Pitsavos C,Antonopoulou S .2016 .Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: A cross-sectional study. Lipids Health Dis, 15 : 1-14.
Okulicz M and Hertig I .2016 .Acute sulforaphane action exhibits hormonal and metabolic activities in the rat: in vivo and in vitro studies. Czech J. Anim. Sci, 61(1) : 22-31.
Pogodzi´nski D,Ostrowska L,Smarkusz-Zarzecka J,Zy´sk B .2022 .Secretome of Adipose Tissue as the Key to Understanding the Endocrine Function of Adipose Tissue. Int. J. Mol. Sci, 23 : 2309.
Santiago-Fernández C,García-Serrano S,Tome M,Valdes S,Ocana-Wilhelmi L,Rodríguez-Canete A,Tinahones FJ,García-Fuentes E,Garrido-Sánchez L .2017 .Ghrelin levels could be involved in the improvement of insulin resistance after bariatric surgery. Endocrinol. Diabetes Nut, 64 : 355-362.
Shoenberg MH,Beger HG .1993 .Reperfusion injury after intesti nal ischemia. Crit. Care Med, 21 : 1376-86.
Sjostrom L,Rissanen A,Andersen T .1998 .Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet, 352 : 167-173.
Silva V,Sousa-Filho CPB,França CD,Otton R .2024 .Controversial anti-obesity actions of epicatechin in male and female mice kept at thermoneutrality. Int. J. Mol. Sci, 1 : 17.
Sethi P,Thillai M,Nain PS,Ahuja A,Aulakh N,Khurana P .2018 .Role of hunger hormone 'Ghrelin' in long-term weight loss following laparoscopic sleeve gastrectomy. Niger J. Surg, 24 : 121-124.
Shah RE,Gayat JL,Januzzi Jr,Sato N,Cohen-Solal A,diSomma S .2014 .Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J. Am. Coll. Cardiol, 63(8) : 778-785.
Song L,Srilakshmi M,Wu Y,Saleem TS .2020 .Sul foraphane attenuates isoproterenolinduced myocardial injury in mice. , : .
Song MY,Kim EK,Moon WS,Park JW,Kim HJ,So HS,Park R,Kwon KB,Park BH .2009 ."Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway. " Toxicol. Appl. Pharmacol, 235(1) : 57-67.
Thounaojam MC,Nammi S,Jadeja R .2013 .Natural products for the treatment of obesity, metabolic syndrome, and type 2 diabetes. Evid. Based Complement Alternat. Med, 871018 : 1-2.
Torres-Fuentes CH,Schellekens TG,Cryan JF .2014 ."A natural solution for obesity: Bioactives for the prevention and treatment of weight gain. A review." Nutr, : .
Uddin MS,Al Mamun A,Jakaria M,Thangapandiyan S,Ahmad J,Rahman MA,Aleya L .2020 .Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders. Science of the Total Environment, 707 : 135624.
Wu YK,Ren ZN,Zhu SL,Wu YZ,Wang G,Zhang H,Chen W,He Z,Ye XL,Zhai QX .2022 .Sulforaphane Ameliorates Non-Alcoholic Fatty Liver Disease in Mice by Promoting FGF21/FGFR1 Signaling Pathway. Acta Pharmacol. Sin, 43 : 1473-1483.
Xu Y,Fu JF,Chen JH,Zhang ZW,Zou ZQ,Han LY,Hu QH,Zhao JS,Zhang XH,Sha YJ .2018 .Sulforaphane Ameliorates Glucose Intolerance in Obese Mice via the Upregulation of the Insulin Signaling Pathway. Food Funct, 9 : 4695-4701.
Yoshitomi R,Yamamoto M,Kumazoe M,Fujimura Y,Yonekura M,Shimamoto Y,Nakasone A,Kondo S,Hattori H,Haseda A,Nishihira J,Tachibana H .2021 .The combined effect of green tea and glucosyl hesperidin in preventing obesity: A randomized placebocontrolled clinical trial. Sci. Rep, 11 : 19067.